Oncotelic Therapeutics, Inc. (OTLC)
0.036
0.00 (0.00%)
USD |
OTCM |
Apr 28, 15:15
Oncotelic Therapeutics EPS Diluted (Quarterly) : 0.5656 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Johnson & Johnson | 2.141 |
| Supernus Pharmaceuticals, Inc. | -0.0716 |
| Sarepta Therapeutics, Inc. | -3.934 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 250.29M |
| Total Expenses (Quarterly) | -250.35M |
| Enterprise Value | 29.03M |
| Earnings Yield | 1.56K% |
| Normalized Earnings Yield | -37.78 |